BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3988126)

  • 1. Extrauterine spread in endometrial carcinoma clinically confined to the uterus.
    Chen SS
    Gynecol Oncol; 1985 May; 21(1):23-31. PubMed ID: 3988126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease.
    Kadar N; Homesley HD; Malfetano JH
    Gynecol Oncol; 1992 Aug; 46(2):145-9. PubMed ID: 1500014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroperitoneal lymph node metastases in Stage I carcinoma of the endometrium: correlation with risk factors.
    Chen SS; Lee L
    Gynecol Oncol; 1983 Dec; 16(3):319-25. PubMed ID: 6654176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.
    Morrow CP; Bundy BN; Kurman RJ; Creasman WT; Heller P; Homesley HD; Graham JE
    Gynecol Oncol; 1991 Jan; 40(1):55-65. PubMed ID: 1989916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of peritoneal cytology in endometrial carcinoma.
    Grimshaw RN; Tupper WC; Fraser RC; Tompkins MG; Jeffrey JF
    Gynecol Oncol; 1990 Jan; 36(1):97-100. PubMed ID: 2295459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial carcinoma: the relevance of cervical cytology.
    DuBeshter B; Warshal DP; Angel C; Dvoretsky PM; Lin JY; Raubertas RF
    Obstet Gynecol; 1991 Mar; 77(3):458-62. PubMed ID: 1992417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium.
    Lurain JR; Rumsey NK; Schink JC; Wallemark CB; Chmiel JS
    Obstet Gynecol; 1989 Aug; 74(2):175-9. PubMed ID: 2748053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative radiation therapy followed by extrafascial hysterectomy in patients with stage II endometrial carcinoma.
    Higgins RV; van Nagell JR; Horn EJ; Roberts SL; Donaldson ES; Gallion HH; DePriest PD; Powell DE; Kryscio RJ
    Cancer; 1991 Sep; 68(6):1261-4. PubMed ID: 1873779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system.
    Grigsby PW; Perez CA; Kuten A; Simpson JR; Garcia DM; Camel HM; Kao MS; Galakatos AE
    Int J Radiat Oncol Biol Phys; 1992; 22(5):905-11. PubMed ID: 1555983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer.
    Tang X; Tanemura K; Ye W; Ohmi K; Tsunematsu R; Yamada T; Katsumata N; Sonoda T
    Jpn J Clin Oncol; 1998 Nov; 28(11):673-8. PubMed ID: 9861234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal cytology in patients with endometrial carcinoma.
    Imachi M; Tsukamoto N; Matsuyama T; Nakano H
    Gynecol Oncol; 1988 May; 30(1):76-86. PubMed ID: 3366396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
    Lax SF; Tamussino KF; Lang PF
    Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
    Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
    Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical hysterectomy for stage I and II endometrial carcinoma: a retrospective analysis of 179 cases.
    Calais G; Le Floch O; Descamps P; Vitu L; Lansac J
    Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):677-83. PubMed ID: 2004943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage II endometrial adenocarcinoma. Memorial Hospital for Cancer, 1949-1965.
    Homesley HD; Boronow RC; Lewis JL
    Obstet Gynecol; 1977 May; 49(5):604-8. PubMed ID: 850578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence factors in endometrial cancer.
    Gusberg SB
    Cancer; 1993 Feb; 71(4 Suppl):1464-6. PubMed ID: 8431881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging laparotomy for endometrial carcinoma: assessment of peritoneal spread.
    Marino BD; Burke TW; Tornos C; Chuang L; Mitchell MF; Tortolero-Luna G; Morris M; Gershenson DM
    Gynecol Oncol; 1995 Jan; 56(1):34-8. PubMed ID: 7821845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial adenocarcinoma: therapeutic impact of preoperative histopathologic examination of endometrial tissue.
    Oakley G; Nahhas WA
    Eur J Gynaecol Oncol; 1989; 10(4):255-60. PubMed ID: 2776782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.